Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents

Entinostat 是一种新型组蛋白去乙酰化酶抑制剂，可有效治疗 B 细胞淋巴瘤，并增强利妥昔单抗和化疗药物的抗肿瘤活性